MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
miRagen Therapeutics Initiates First Clinical Trial for MRG-106 in Lymphoma Patients.
Brennan CaruthersMarch 2, 2016
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

F‐star Announces Collaborative Agreement with Denali Therapeutics for the Development of a Multispecific Antibody Platform to Deliver Therapeutics Across the Blood‐Brain Barrier.

Brennan CaruthersAugust 25, 2016
Next

Thrasos Announces Promising Results for Phase 2 THR-184 Dose Ranging Clinical Study for the Prevention of Acute Kidney Injury (AKI).

Brennan CaruthersFebruary 29, 2016

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact